Dr. Ferguson specializes in the surgical management of diseases of the chest. His most active areas of surgical management include lung cancer, benign and malignant esophageal diseases, mesothelioma, and thymoma. He has broad experience in using minimally invasive techniques, and performs 80% of his operations either using VATS, robotics, or laparoscopy. He is also adept at performing traditional open operations for more complex disease.
As founding Program Director of the University of Chicago Cardiothoracic Fellowship Program, Dr. Ferguson supervises the training of cardiothoracic fellows. He has served on the boards and committees of numerous national societies and institutions including the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and CTSNet.org.
Dr. Ferguson is the author of more than 100 chapters in medical textbooks. He has edited or written 8 books, and has completed 3 editions of Difficult Decisions in Thoracic Surgery. He is the editor for Difficult Decisions in Surgery, a series of books highlighting decision making in a variety of surgical subspecialties. He has also published more than 350 papers and abstracts in medical journals. Dr. Ferguson serves as a deputy editor for the Annals of Thoracic Surgery, is on the editorial board of 3 other journals, and is Editor of CTSNet.org. He serves as the Executive Director of the International Society for Diseases of the Esophagus.
Among his research interests are risk analysis, long-term outcomes after lung resection and esophageal resection, development of simulation methods for surgical training, advanced techniques in surgical education, and factors that influence medical decision making including gender and racial/ethnic bias. His educational background includes an undergraduate degree from Harvard College and an MD degree from The University of Chicago. His surgical training and fellowship in medical education took place at The University of Chicago.
University of Chicago
Chicago, IL
- Education
2011
University of Chicago
Chicago, IL
- Cardiothoracic Surgery
1984
University of Chicago
Chicago, IL
- General Surgery
1982
University of Chicago
Chicago, IL
MD
1977
Harvard College
Cambridge, MA
BA
1973
Caustic Ingestion-The Haves and the Have Nots.
Ferguson MK. Caustic Ingestion-The Haves and the Have Nots. JAMA Surg. 2022 02 01; 157(2):119.
PMID: 34878518
Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy.
Liu L, Zhang J, Ferguson MK, Appelbaum D, Zhang JX, Pu Y. Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy. Front Biosci (Landmark Ed). 2022 01 12; 27(1):16.
PMID: 35090321
Thoracoscopic sympathectomy decreases disease burden in patients with medically refractory ventricular arrhythmias.
Lee ACH, Tung R, Ferguson MK. Thoracoscopic sympathectomy decreases disease burden in patients with medically refractory ventricular arrhythmias. Interact Cardiovasc Thorac Surg. 2022 Jan 07.
PMID: 35015855
Knowledge of surgical management of hyperhidrosis among primary care physicians and the general public.
Lee ACH, Ferguson MK. Knowledge of surgical management of hyperhidrosis among primary care physicians and the general public. Interact Cardiovasc Thorac Surg. 2022 Jan 07.
PMID: 35015865
Gender Bias in Judging Frailty and Fitness for Lung Surgery.
Lee ACH, Madariaga MLL, Liao C, Ferguson MK. Gender Bias in Judging Frailty and Fitness for Lung Surgery. Ann Thorac Surg. 2021 Dec 10.
PMID: 34902299
Caustic Ingestion-The Haves and the Have Nots.
Ferguson MK. Caustic Ingestion-The Haves and the Have Nots. JAMA Surg. 2021 Dec 08.
PMID: 34878518
Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation.
Erwin PA, Lee AC, Ahmad U, Antonoff M, Arndt A, Backhus L, Berry M, Birdas T, Cassivi SD, Chang AC, Cooke DT, Crabtree T, DeCamp M, Donington J, Fernandez F, Force S, Gaissert H, Hofstetter W, Huang J, Kent M, Kim AW, Lin J, Martin LW, Meyerson S, Mitchell JD, Molena D, Odell D, Onaitis M, Puri V, Putnam JB, Reddy R, Schipper P, Seder CW, Shrager J, Tong B, Veeramachaneni N, Watson T, Whyte R, Ferguson MK. Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. Ann Thorac Surg. 2021 Oct 21.
PMID: 34688617
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
Gutiontov SI, Turchan WT, Spurr LF, Rouhani SJ, Chervin CS, Steinhardt G, Lager AM, Wanjari P, Malik R, Connell PP, Chmura SJ, Juloori A, Hoffman PC, Ferguson MK, Donington JS, Patel JD, Vokes EE, Weichselbaum RR, Bestvina CM, Segal JP, Pitroda SP. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
PMID: 34625620
Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer.
D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W, Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schröder W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 09 01; 156(9):836-845.
PMID: 34160587
Pulmonary Parenchymal Changes in COVID-19 Survivors.
Diaz A, Bujnowski D, McMullen P, Lysandrou M, Ananthanarayanan V, Husain AN, Freeman R, Vigneswaran WT, Ferguson MK, Donington JS, Madariaga MLL, Abdelsattar ZM. Pulmonary Parenchymal Changes in COVID-19 Survivors. Ann Thorac Surg. 2021 Jul 31.
PMID: 34343471